Document Type : Review Article


1 Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

2 Department of Epidemiology and Biostatics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran

3 Biotechnology and Biological Science Research Center, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran


SARS-CoV- 2 is the causative agent of the global pandemic, also known as Covid-19. This virus belongs to a group of coronaviruses and has affected more than ten million people across the globe, causing nearly half a million deaths worldwide. The pandemic has spread worldwide, originating in the Wuhan Hubei province of China in 2019. The disease is a significant challenge as there is no antiviral treatment. This review will address current trends and emerging new methods for detecting SARS-CoV-2 in the laboratoryat present. Reverse transcriptase PCR or RT-PCR is the gold standard for detecting SARS-CoV-2 disease. The seroprevalence of Covid-19 is performed using antibody detection tests using ELISA and antigen detection as rapid tests. In clinical practice, preliminary disease identification is made based on Chest radiographs, computed tomography, and positron emission tomography (PET) scans. As the pandemic has progressed, newer methods of detection like CRISPR, nanotechnology-enabled solutions, and biosensors have emerged as new methods of detecting SARS-CoV-2.  

Graphical Abstract

Current trends and new methods of detection of SARS-CoV-2 infection


Main Subjects

Selected author of this article by journal

ِDr. Mohammad Reza Mohammadi
Tarbiat Modares University

Google Scholar

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit:


Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.


Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

  1. Vickers NJ (2017) Animal communication: when i’m calling you, will you answer too? Current Biology 27(14):R713-R715. doi:
  2. Peiris J, Lai S, Poon L, Guan Y, Yam L, Lim W, Nicholls J, Yee W, Yan W, Cheung M (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet 361(9366):1319-1325. doi:
  3. Cui J, Li F, Shi Z-L (2019) Origin and evolution of pathogenic coronaviruses. Nature reviews microbiology 17(3):181-192. doi:
  4. Fazeli-Nasab B (2021) Biological Evaluation of Coronaviruses and the Study of Molecular Docking, Linalool, and Thymol as orf1ab Protein Inhibitors and the Role of SARS-CoV-2 Virus in Bioterrorism. journal of ilam university of medical sciences 28(6):77-96. doi:
  5. Wacharapluesadee S, Tan CW, Maneeorn P, Duengkae P, Zhu F, Joyjinda Y, Kaewpom T, Chia WN, Ampoot W, Lim BL (2021) Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia. Nature communications 12(1):1-9. doi:
  6. Liu D, Liang J, Fung T (2020) Human coronavirus-229E,-OC43,-NL63, and-HKU1. Epub ahead of print 7 May 2020. Reference Module in Life Sciences 2020:1-13. doi:
  7. Melin AD, Janiak MC, Marrone F, Arora PS, Higham JP (2020) Comparative ACE2 variation and primate COVID-19 risk. Communications biology 3(1):1-9. doi:
  8. Mata GFd, Fernandes DE, Luciano EdP, Sales GTM, Riguetti MTP, Kirsztajn GM (2021) Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV. Journal of Venomous Animals and Toxins including Tropical Diseases 27:1-9. doi:
  9. Yanez ND, Weiss NS, Romand J-A, Treggiari MM (2020) COVID-19 mortality risk for older men and women. BMC Public Health 20(1):1-7. doi:
  10. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, Rom W, Sanda M, Sorbara L, Stass S (2009) Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. Journal of proteome research 8(1):113-117. doi:
  11. Shrestha LB, Pokharel K (2020) Standard operating procedure for specimen collection, packaging and transport for diagnosis of SARS-COV-2. JNMA: Journal of the Nepal Medical Association 58(228):627. doi:
  12. Carvalho AF, Rocha RP, Gonçalves AP, Silva T, Sato HI, Vuitika L, Bagno FF, Sérgio SA, Figueiredo MM, Martins RB (2021) The use of denaturing solution as collection and transport media to improve SARS-CoV-2 RNA detection and reduce infection of laboratory personnel. Brazilian Journal of Microbiology 52(2):531-539. doi:
  13. Gualano G, Musso M, Mosti S, Mencarini P, Mastrobattista A, Pareo C, Zaccarelli M, Migliorisi P, Vittozzi P, Zumla A (2020) Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: a case report. International Journal of Infectious Diseases 97:174-176. doi:
  14. Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, Soni D, Das S, Hasan M, Patel M (2021) Diagnostics for SARS-CoV-2 infections. Nature materials 20(5):593-605. doi:
  15. Walsh KA, Jordan K, Clyne B, Rohde D, Drummond L, Byrne P, Ahern S, Carty PG, O'Brien KK, O'Murchu E (2020) SARS-CoV-2 detection, viral load and infectivity over the course of an infection. Journal of Infection 81(3):357-371. doi:
  16. Kirkland PD, Frost MJ (2020) The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2. Pathology 52(7):811-814. doi:
  17. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VY, Chen H, Mubareka S, Gubbay JB, Chan WC (2020) Diagnosing COVID-19: the disease and tools for detection. ACS nano 14(4):3822-3835. doi:
  18. Padhye NS (2021) Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19. MedRxiv 2021:2020.2004. 2024.20078949. doi:
  19. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25(3):2000045
  20. Holohan C, Hanrahan S, Feely N, Li P, O'Connell J, Moss C, Carr M, Tagit O, Lee GU (2021) Influence of viral transport media and freeze–thaw cycling on the sensitivity of qRT-PCR detection of SARS-CoV-2 nucleic acids. Nanoscale 13(37):15659-15667. doi:
  21. Byrnes SA, Gallagher R, Steadman A, Bennett C, Rivera R, Ortega C, Motley ST, Jain P, Weigl BH, Connelly JT (2021) Multiplexed and extraction-free amplification for simplified SARS-CoV-2 RT-PCR tests. Analytical chemistry 93(9):4160-4165. doi:
  22. Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J, di Ruffano LF (2020) Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database of Systematic Reviews. doi:
  23. Sethuraman N, Jeremiah SS, Ryo A (2020) Interpreting diagnostic tests for SARS-CoV-2. Jama 323(22):2249-2251. doi:
  24. Sekine T, Perez-Potti A, Rivera-Ballesteros O, Strålin K, Gorin J-B, Olsson A, Llewellyn-Lacey S, Kamal H, Bogdanovic G, Muschiol S (2020) Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183(1):158-168. e114. doi:
  25. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581(7809):465-469. doi:
  26. Silveira MF, Mesenburg MA, Dellagostin OA, de Oliveira NR, Maia MA, Santos FD, Vale A, Menezes A, Victora GD, Victora CG (2021) Time-dependent decay of detectable antibodies against SARS-CoV-2: a comparison of ELISA with two batches of a lateral-flow test. Brazilian Journal of Infectious Diseases 25(4):101601. doi:
  27. Matricardi PM, Dal Negro RW, Nisini R (2020) The first, holistic immunological model of COVID‐19: implications for prevention, diagnosis, and public health measures. Pediatric Allergy and Immunology 31(5):454-470. doi:
  28. Murray PR (2015) The clinician and the microbiology laboratory. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015:191. doi:
  29. Watson J, Whiting PF, Brush JE (2020) Interpreting a covid-19 test result. Bmj 369:m1808 doi:
  30. Kirkeby L, Rasmussen TT, Reinholdt J, Kilian M (2000) Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria. Clinical Diagnostic Laboratory Immunology 7(1):31-39. doi:
  31. Riollano‐Cruz M, Akkoyun E, Briceno‐Brito E, Kowalsky S, Reed J, Posada R, Sordillo EM, Tosi M, Trachtman R, Paniz‐Mondolfi A (2021) Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience. Journal of Medical Virology 93(1):424-433. doi:
  32. Delgado MF, Coviello S, Monsalvo A, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang H-Y, Mitzner W (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nature medicine 15(1):34-41. doi:
  33. Peghin M, De Martino M, Fabris M, Palese A, Visintini E, Graziano E, Gerussi V, Bontempo G, D’Aurizio F, Biasotto A (2021) The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery. Journal of Clinical Microbiology 59(11):e01138-01121. doi:
  34. Ai Y, Davis A, Jones D, Lemeshow S, Tu H, He F, Ru P, Pan X, Bohrerova Z, Lee J (2021) Wastewater SARS-CoV-2 monitoring as a community-level COVID-19 trend tracker and variants in Ohio, United States. Science of the Total Environment 801:149757. doi:
  35. Long Q-X, Tang X-J, Shi Q-L, Li Q, Deng H-J, Yuan J, Hu J-L, Xu W, Zhang Y, Lv F-J (2020) Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature medicine 26(8):1200-1204. doi:
  36. Ali Z, Aman R, Mahas A, Rao GS, Tehseen M, Marsic T, Salunke R, Subudhi AK, Hala SM, Hamdan SM (2020) iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus research 288:198129. doi:
  37. Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A (2020) CRISPR–Cas12-based detection of SARS-CoV-2. Nature Biotechnology 38(7):870-874. doi:
  38. Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F (2019) SHERLOCK: nucleic acid detection with CRISPR nucleases. Nature Protocols 14(10):2986-3012. doi:
  39. Garcia-Venzor A, Rueda-Zarazua B, Marquez-Garcia E, Maldonado V, Moncada-Morales A, Olivera H, Lopez I, Zuñiga J, Melendez-Zajgla J (2021) SARS-CoV-2 direct detection without RNA isolation with loop-mediated isothermal amplification (LAMP) and CRISPR-Cas12. Frontiers in medicine 8:627679. doi:
  40. Gupta R, Kazi TA, Dey D, Ghosh A, Ravichandiran V, Swarnakar S, Roy S, Biswas SR, Ghosh D (2021) CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout. Applied microbiology and biotechnology 105(20):7593-7605. doi:
  41. Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali M, Scott JA, Vitale F, Unal MA, Mattevi C (2020) Toward nanotechnology-enabled approaches against the COVID-19 pandemic. ACS nano 14(6):6383-6406. doi:
  42. Rabiee N, Bagherzadeh M, Ghasemi A, Zare H, Ahmadi S, Fatahi Y, Dinarvand R, Rabiee M, Ramakrishna S, Shokouhimehr M (2020) Point-of-use rapid detection of SARS-CoV-2: nanotechnology-enabled solutions for the COVID-19 pandemic. International Journal of Molecular Sciences 21(14):5126. doi:
  43. Rabiee N, Akhavan O, Fatahi Y, Ghadiri AM, Kiani M, Makvandi P, Rabiee M, Nicknam MH, Saeb MR, Varma RS (2022) CaZnO-based nanoghosts for the detection of ssDNA, pCRISPR and recombinant SARS-CoV-2 spike antigen and targeted delivery of doxorubicin. Chemosphere):135578. doi:
  44. Nguyen NN, McCarthy C, Lantigua D, Camci-Unal G (2020) Development of diagnostic tests for detection of SARS-CoV-2. Diagnostics 10(11):905. doi:
  45. Hajian R, Balderston S, Tran T, DeBoer T, Etienne J, Sandhu M, Wauford NA, Chung J-Y, Nokes J, Athaiya M (2019) Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor. Nature biomedical engineering 3(6):427-437. doi:
  46. Seo G, Lee G, Kim MJ, Baek S-H, Choi M, Ku KB, Lee C-S, Jun S, Park D, Kim HG (2020) Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS nano 14(4):5135-5142. doi:
  47. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, Schluger NW, Volpi A, Yim J-J, Martin IB (2020) The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society. Chest 158(1):106-116. doi:
  48. Beeching NJ, Fletcher TE, Fowler R (2020) BMJ best practice. Coronavirus Disease 2019 (COVID-19). British Med J 24
  49. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R (2022) Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls [internet]):Bookshelf ID: NBK554776. doi:PMID: 32150360
  50. Ai J-W, Zhang H-C, Xu T, Wu J, Zhu M, Yu Y-Q, Zhang H-Y, Li Y, Zhou X, Shen Z (2020) Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China. MedRxiv). doi:
  51. Gao L, Zhang J (2020) Pulmonary high-resolution computed tomography (HRCT) findings of patients with early-stage coronavirus disease 2019 (COVID-19) in Hangzhou, China. Medical science monitor: international medical journal of experimental and clinical research 26:e923885-923881. doi:
  52. Kostakoglu L, Agress Jr H, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23(2):315-340. doi:
  53. Colandrea M, Gilardi L, Travaini LL, Fracassi SL, Funicelli L, Grana CM (2020) 18F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces. Japanese Journal of Radiology 38(11):1007-1011. doi: